Directory
>
Andrew Erdman
Andrew Erdman
Intern - General Surgery | Genentech
California, San Francisco, United States
Andrew Erdman
Summary
Andrew Erdman is a seasoned executive in the pharmaceutical industry, currently serving as the Vice President and Global Head of Early Development Safety at Genentech. With an extensive background in clinical pharmacology and drug safety, he has held various leadership roles at Genentech, where he has significantly contributed to the safety of marketed medicines and early-stage development. Andrew's academic credentials include a medical degree from the University of California, Davis, and a bachelor's degree in Kinesiology from UCLA. His career began with a postdoctoral fellowship at UCSF, and he has built a robust career in drug safety and clinical development across major biotech firms. Known for his strategic vision and expertise in safety protocols, Andrew is passionate about advancing medical innovation while ensuring patient safety. He is committed to fostering collaboration within teams to enhance drug development processes. Outside of his professional life, he is likely to have interests that align with healthcare advancements and leadership development.
Andrew Erdman
Work Experience
Vice President, Global Head of Early Development Safety, Late Stage and Marketed Medicines Safety at
Genentech
November 2021 - Present
Andrew Erdman
Education
University of California, Davis - School of Medicine, MD, Medicine
January 1992 - January 1996
University of California, Los Angeles, BS, Kinesiology (Physiologic Sciences)
January 1987 - January 1992
Frequently Asked Questions about Andrew Erdman
What is Andrew Erdman email address?
Andrew Erdman's primary email address is *************@gene.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Andrew Erdman work for?
Andrew Erdman is a Intern - General Surgery at Genentech.
Where Andrew Erdman graduated from?
Andrew Erdman holds a degree in null from University of California, Davis - School of Medicine.
How can I directly contact Andrew Erdman?
To contact Andrew Erdman directly, you can use the email address *************@gene.com. Complete contact information is available upon registration with Muraena.
Who is Andrew Erdman?
Andrew Erdman is a seasoned executive in the pharmaceutical industry, currently serving as the Vice President and Global Head of Early Development Safety at Genentech. With an extensive background in clinical pharmacology and drug safety, he has held various leadership roles at Genentech, where he has significantly contributed to the safety of marketed medicines and early-stage development. Andrew's academic credentials include a medical degree from the University of California, Davis, and a bachelor's degree in Kinesiology from UCLA. His career began with a postdoctoral fellowship at UCSF, and he has built a robust career in drug safety and clinical development across major biotech firms. Known for his strategic vision and expertise in safety protocols, Andrew is passionate about advancing medical innovation while ensuring patient safety. He is committed to fostering collaboration within teams to enhance drug development processes. Outside of his professional life, he is likely to have interests that align with healthcare advancements and leadership development.
Andrew`s contact details
*************@gene.com
Colleagues
Senior Environment Health and Safety (EHS) Specialist
Research Assistant, Stanford Prevention Research Center
Director of Diversity and Outreach Programs
Scientist 1, Diagnostic Assay Development
Account Supervisor
Judicial Law Clerk
Research Associate
Director, Creative Operations + Medical Life Sciences
Technical Service Associate
Zycos Inc